Literature DB >> 12531168

Depression and insomnia: questions of cause and effect.

Lisa Lustberg1, Charles F. Reynolds.   

Abstract

Chronic insomnia is a risk factor for the development of psychiatric disorders, including depression, as well as a prodrome of major depressive episodes, a consequence or complication of depression that often persists beyond the clinical episode, and a prognostic indicator of long-term illness course and treatment response. In addition, sleep is physiologically abnormal in persons at risk for depression; for example, shortened REM sleep latency is present not only during clinical episodes of depression, but also before the clinical episode in subjects at risk for depressive illness. Although insomnia usually disappears as depression is treated, it may persist, indicating heightened vulnerability to depressive relapse or recurrence. Physiological changes in sleep related to depression correlate with the likelihood of response to psychotherapy alone and may also identify which patients are unlikely to do well with psychosocial treatment and, therefore, to need somatic therapy in order to preserve recovery. Electroencephalographic (EEG) sleep changes also correlate with the speed of response and with the brittleness or durability of response (i.eprobability of relapse or recurrence). These observations suggest a close relationship between the regulation of sleep and the regulation of mood. The importance of this relationship is further underscored by recent brain imaging studies of sleep and sleep deprivation in patients with major depression. For example, therapeutic sleep deprivation (TSD) may serve as both a catalyst of rapid antidepressant activity and as a probe of treatment resistance. TSD's effects on brain metabolic rates, especially in limbic areas, may correlate with a therapeutic response to a night of sleep loss and to antidepressant medication. Finally, treating chronic insomnia with newer selective serotonin reuptake inhibitor (SSRI) antidepressant medication may represent an opportunity for preventing complications of insomnia, including depressive illness.

Entities:  

Year:  2000        PMID: 12531168     DOI: 10.1053/smrv.1999.0075

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  60 in total

1.  High dosage of hypnotics predicts subsequent sleep-related breathing disorders and is associated with worse outcomes for depression.

Authors:  Cheng-Ta Li; Ya-Mei Bai; Ying-Chiao Lee; Wei-Chung Mao; Mu-Hong Chen; Pei-Chi Tu; Ying-Sheue Chen; Tzeng-Ji Chen; Wen-Hang Chang; Tung-Ping Su
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

Review 2.  Aging, circadian rhythms and depressive disorders: a review.

Authors:  Inês Campos Costa; Hugo Nogueira Carvalho; Lia Fernandes
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

3.  Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Authors:  Venkatramanujam Srinivasan; Daniel P Cardinali; Uddanapalli S Srinivasan; Charanjit Kaur; Gregory M Brown; D Warren Spence; Rüdiger Hardeland; Seithikurippu R Pandi-Perumal
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

4.  Efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized trial.

Authors:  Philip Cheng; Annemarie I Luik; Cynthia Fellman-Couture; Edward Peterson; Christine L M Joseph; Gabriel Tallent; Kieulinh Michelle Tran; Brian K Ahmedani; Timothy Roehrs; Thomas Roth; Christopher L Drake
Journal:  Psychol Med       Date:  2018-05-24       Impact factor: 7.723

5.  Longitudinal relations between maternal depressive symptoms and child sleep problems: the role of parasympathetic nervous system reactivity.

Authors:  Peggy S Keller; Chrystyna D Kouros; Stephen A Erath; Ronald E Dahl; Mona El-Sheikh
Journal:  J Child Psychol Psychiatry       Date:  2013-10-09       Impact factor: 8.982

6.  Depression prevention via digital cognitive behavioral therapy for insomnia: a randomized controlled trial.

Authors:  Philip Cheng; David A Kalmbach; Gabriel Tallent; Christine Lm Joseph; Colin A Espie; Christopher L Drake
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

7.  Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment.

Authors:  Peter L Franzen; Daniel J Buysse; Mordechai Rabinovitz; Bruce G Pollock; Francis E Lotrich
Journal:  Psychiatry Res       Date:  2010-04-09       Impact factor: 3.222

8.  Perceived neighborhood quality, sleep quality, and health status: evidence from the Survey of the Health of Wisconsin.

Authors:  Lauren Hale; Terrence D Hill; Elliot Friedman; F Javier Nieto; Loren W Galvao; Corinne D Engelman; Kristen M C Malecki; Paul E Peppard
Journal:  Soc Sci Med       Date:  2012-08-07       Impact factor: 4.634

Review 9.  Sleep disturbances in caregivers of persons with dementia: contributing factors and treatment implications.

Authors:  Susan M McCurry; Rebecca G Logsdon; Linda Teri; Michael V Vitiello
Journal:  Sleep Med Rev       Date:  2007-02-06       Impact factor: 11.609

10.  Comparing neural correlates of REM sleep in posttraumatic stress disorder and depression: a neuroimaging study.

Authors:  Sommer Ebdlahad; Eric A Nofzinger; Jeffrey A James; Daniel J Buysse; Julie C Price; Anne Germain
Journal:  Psychiatry Res       Date:  2013-12-30       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.